XTX Topco’s Turn Therapeutics TTRX Stock Holding History

XTX Topco’s Portfolio TTRX Stock Details TTRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,727	Closed	-$63.1K	–	4896
2026 Q1	$63.1K	Sell	19,727 -5,446	-22%	-$21.2K	﹤0.01%	3254
2025 Q4	$99.2K	Buy	+25,173	New	+$105K	﹤0.01%	2641

Other funds holding TTRX

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return

XTX Topco's TTRX Position: Q2 2026 in Review

XTX Topco sold out of Turn Therapeutics (TTRX) in Q2 2026, closing a stake of 19,727 shares — an estimated $63.1K sold.

XTX Topco first reported a position in TTRX in Q4 2025 and held it in 2 quarters. The position peaked at $99.2K in Q4 2025. 29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

XTX Topco reported no remaining Turn Therapeutics position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 19,727 Turn Therapeutics shares in Q2 2026, an estimated $63.1K.
XTX Topco first reported a position in Turn Therapeutics in Q4 2025 and held it in 2 quarters.
XTX Topco's Turn Therapeutics position peaked at $99.2K in Q4 2025.
29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.